Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DuoGel
- Development stage
- Phase 1
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DuoGel is a combination pharmaceutical drug formulated as a syrup, primarily used for the treatment of acidity, stomach ulcers, and bloating. It works through a triple-action mechanism: domperidone acts as a prokinetic agent, enhancing the movement of the stomach and intestines; magaldrate functions as an antacid, neutralizing excessive stomach acid; and simethicone serves as an antiflatulent, reducing the surface tension of gas bubbles to facilitate their passage. This synergistic action provides comprehensive relief from symptoms such as nausea, stomach pain, irritation, heartburn, and gas. It is a prescription medicine and is typically taken orally.
- Brand names
- DuoGelDuogel SyrupDuogel Products
02
Targets
DRD2 (Dopamine D2 Receptor)
Beyond the preview
Go deeper on DuoGel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DuoGel.